NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-129-2021-1-US-01 AQP1 Gene Therapy To Prevent Radiation Induced Salivary Hypofunction US 63/297,342 Expired
NIAID E-088-2022-0-US-01 Novel Immunogens For Influenza Virus Vaccines US 63/297,523 Expired
NCATS E-057-2022-0-US-01 ESTRADIOL PRODRUGS AND METHODS OF USE THEREOF US 63/297,655 Expired
NCI E-014-2017-0-US-07 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF US DIV 17/570,248 12012455 Issued PDF
NIBIB E-237-2020-0-PCT-02 SYSTEMS AND METHODS FOR PRODUCING ISOTROPIC IN-PLANE SUPER-RESOLUTION IMAGES FROM LINE-SCANNING CONFOCAL MICROSCOPY PCT PCT PCT/US2022/011484 Expired
NIBIB E-168-2021-1-US-01 Systems and Methods for Three-Dimensional Structured Illumination Microscopy With Isotropic Spatial Resolution Using Computational Means US 63/297,162 Expired
NHLBI E-144-2021-0-US-01 Tissue Cutting Systems and Methods US 63/297,226 Expired
NCI E-135-2019-0-AU-04 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 AU National Stage 2020308004 Pending
NIDDK E-051-2021-0-PCT-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS PCT PCT COMB PCT/US2022/011226 Expired
NCATS E-262-2016-0-US-06 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS US CON 17/568,023 Abandoned
NHGRI E-044-2013-1-JP-19 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA JP DIV 2022-000125 Abandoned
NIAID E-132-2021-0-US-01_82723 Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein and Uses Thereof US 63/296,380 Expired
NIAID E-134-2020-1-PCT-01 ANTIBODY-GUIDED PCSK9-MIMICKING IMMUNOGENS LACKING 9-RESIDUE SEQUENCE OVERLAP WITH HUMAN PROTEINS PCT PCT COMB PCT/US2021/065856 Expired
NCI E-046-2022-0-US-01 Neoantigen T Cell Therapy With Neoantigen Vaccination As A Combination Immunotherapy Against Cancer US 63/295,762 Expired
NCI E-042-2014-0-JP-32 Chimeric Antigen Receptors Targeting CD-19 JP DIV 2021-215427 Issued
NHGRI E-034-2022-0-US-01 IMPROVED GENE THERAPY CONSTRUCTS FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA US 63/294,511 Expired
NHLBI E-186-2014-1-JP-16 SUPERAGONISTS, PARTIAL AGONISTS AND ANTAGONISTS OF INTERLEUKIN-2 JP DIV 2021-213818 Issued
NCI E-103-2019-0-US-07 MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE US National Stage 17/623,370 Pending
NCI E-135-2019-0-CN-07 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 CN National Stage 202080047882.0 Pending
NIDDK E-138-2017-0-IL-18 COMPOUNDS AND METHODS FOR TREATING NEUROLOGICAL AND CARDIOVASCULAR CONDITIONS IL DIV 289423 Pending
NCI E-135-2019-0-JP-10 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 JP National Stage 2021-576970 Issued
NCI E-135-2019-0-BR-05 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 BR National Stage BR112021026408-6 Pending
NCATS E-047-2021-0-PC-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2021/065037 Expired
NCI E-171-2020-0-PCT-02 EXO VII Inhibitor and Quinolone Antibiotic
Combination Useful for Treating Bacterial Infection 		PCT PCT PCT/US2021/064996 Expired
NCATS E-118-2019-0-CN-01 SMALL MOLECULE BROMODOMAIN INHIBITORS AND USES THEREOF CN National Stage 202080045657.3 Pending
NCI E-022-2017-0-EP-05 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT EP DIV 21217161.5 Abandoned
NCATS E-022-2022-0-US-01 METHODS AND SYSTEMS FOR ANALYZING TARGET ENGAGEMENT DATA FROM BIOLOGICAL ASSAYS US 63/292,919 Expired
NIDDK E-085-2022-0-US-01 Next Generation Piggybac Transposasome US 63/292,821 Expired
NICHD E-210-2021-0-US-02 Kits And Methods For Predictions And Treatment Of Preeclampsia US CON 17/558,248 11782065 Issued PDF
NCI E-042-2014-0-US-31 CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 US CON 17/557,845 Pending
NIAID E-086-2018-3-EP-04 Zika Viral Antigen Constructs EP DIV 21216477.6 Abandoned
NCI E-257-2009-1-US-25 Use Of IL-15 To Increase Thymic Output US DIV 17/558,365 Abandoned
NCI E-135-2019-0-US-16 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 US National Stage 17/620,942 12479902 Issued PDF
NCI E-039-2017-0-US-05 METHODS OF TREATMENT USING PHENYL INDOLE ALLOSTERIC INHIBITORS OF P97 ATPASE US CON 17/556,147 Pending
NEI E-070-2019-0-JP-06 INTERLEUKIN-27 PRODUCING B-CELL POPULATION AND USES THEREOF JP National Stage 2021-575486 Issued
NCI E-205-2016-0-US-06 NANOPARTICLE TO TARGET CANCER US DIV 17/555,285 11696922 Issued PDF
NEI E-013-2021-0-PCT-02 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE PCT PCT PCT/US2021/064086 Expired
NEI E-070-2019-0-US-07 INTERLEUKIN-27 PRODUCING B-CELLS AND USES THEREOF US National Stage 17/620,248 Pending
NHGRI E-104-2019-0-US-04 SYNTHETIC GENES FOR THE TREATMENT OF PROPIONIC ACIDEMIA CAUSED BY
MUTATIONS IN PROPIONYL-COA CARBOXYLASE ALPHA 		US National Stage 17/620,331 Abandoned
NCI E-033-2022-0-US-01 ANTI-MESOTHELIN POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US 63/290,761 Expired
NIAID E-001-2017-1-US-04 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION US DIV 17/553,139 11926656 Issued PDF
NCI E-176-2014-0-JP-63 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS JP DIV 2021-203953 Issued
NHGRI E-034-2019-0-HK-17 NON-DISRUPTIVE GENE THERAPY FOR THE TREATMENT OF MMA HK CN 62021044683.2 Abandoned
NCI E-135-2019-0-CA-06 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 CA National Stage 3144070 Pending
NCI E-135-2019-0-MX-11 T CELL RECEPTORS RECOGNIZING R175H OR Y220C MUTATION IN P53 MX National Stage MX/a/2021/015877 Pending
NIAAA E-191-2021-0-US-01 SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS US 63/290,409 Expired
NIAID E-024-2021-0-PCT-02 DNA VECTOR AND USES THEREOF FOR DETECTING HIV AND SIV PCT PCT PCT/US2021/063514 Expired
NCATS E-046-2021-0-PC-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2021/063567 Expired
NIAID E-030-2021-0-PCT-02 HUMAN MONOCLONAL ANTIBODIES TARGETING SARS-COV-2 PCT PCT PCT/US2021/063525 Expired
NICHD E-184-2021-0-US-01 LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO US 63/289,965 Expired